From August 23, 2022 to September 30, 2022, the company has repurchased 242,411 shares, representing 0.29% for $1.17 million. With this, the company has completed the repurchase of 242,411 shares, representing 0.29% for $1.17 million under the buyback announced on August 30, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.755 USD | +0.29% | -3.04% | -7.63% |
Apr. 18 | Verastem Names John Hayslip as Chief Medical Officer | MT |
Apr. 15 | I-Mab Announces Chief Medical Officer Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.63% | 141M | |
+34.35% | 693B | |
+29.39% | 584B | |
-3.49% | 372B | |
+20.15% | 332B | |
+6.19% | 294B | |
+14.11% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+9.21% | 168B |
- Stock Market
- Equities
- IMAB Stock
- News I-Mab
- Tranche Update on I-Mab's Equity Buyback Plan announced on August 30, 2022.